Form 4: BDX Executive Michael Garrison Boosts Stake

Becton Dickinson & Co. EVP Michael Garrison increased his direct beneficial ownership of common stock through equity awards and tax-related dispositions.

Summary

• Michael David Garrison, EVP & President of Medical Essential & BioPharm at Becton Dickinson & Co. (BDX), reported changes in his beneficial ownership of common stock.
• On November 26, 2025, Garrison acquired 7,568 shares of common stock through restricted stock units awarded under the company's 2004 Employee and Director Equity-Based Compensation Plan.
• On the same date, he also acquired 3,048 shares of common stock upon the vesting of performance-based equity awards.
• Concurrently, 1,769 shares of common stock were disposed of to cover withholding taxes related to the vesting of performance units and previously reported restricted stock units.
• Following these transactions, Garrison directly beneficially owns 13,734 shares of Becton Dickinson & Co. common stock.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to executive compensation, including equity awards and tax withholding. The net increase in direct beneficial ownership is slightly positive for executive alignment, but the overall event is neutral in terms of market sentiment.

Positives

• Michael David Garrison's direct beneficial ownership of Becton Dickinson & Co. common stock increased by a net of 8,847 shares (7,568 + 3,048 1,769), demonstrating continued alignment with shareholder interests.
• The acquisition of shares through restricted stock units and performance-based equity awards indicates the executive is receiving compensation tied to company performance and long-term incentives.

Negatives

• A portion of shares (1,769) was disposed of to cover withholding taxes, which is a routine event for equity award vesting and not indicative of a negative outlook.

Future Outlook

This filing is a report of insider transactions and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

Insider transactions, particularly those related to equity compensation and tax withholding, are common occurrences across all industries for executives of publicly traded companies. This filing reflects a standard compensation event for a senior executive in the medical technology sector.

Stakeholder Impact

• Shareholders: The increase in direct beneficial ownership by a key executive may be viewed positively as it aligns management's interests with those of shareholders.
• Employees: The report details the vesting of equity awards, which is a common component of executive compensation plans and can serve as a benchmark for other employee equity programs.

Key Dates

Keywords

Becton Dickinson, BDX, Form 4, Insider Transaction, Equity Awards, Restricted Stock Units, Performance Shares, Executive Compensation